Paper52401
Enhanced cell killing by bleomycin and 43 degrees hyperthermia and the inhibition of recovery from potentially lethal damage.
Braun J and 1 other. Cancer Res, 1975. Cited by 131 papers, by iCite.
Cite this record
ConductScience Library. Enhanced cell killing by bleomycin and 43 degrees hyperthermia and the inhibition of recovery from potentially lethal damage. Papers, record 52401. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/52401
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enhanced cell killing by bleomycin and 43 degrees hyperthermia and the inhibition of recovery from potentially lethal damage.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bleomycin | Major topic |
| Cells, Cultured | Major topic |
| Hot Temperature | Major topic |
| Animals | |
| Cell Line | |
| Cell Membrane Permeability | |
| Cell Survival | |
| Cricetinae | |
| DNA Repair | |
| Dose-Response Relationship, Drug | |
| In Vitro Techniques | |
| Kinetics | |
| Time Factors |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39398925 | Limb salvage using radical combined hyperthermia and radiotherapy for myxofibrosarcoma of the lower leg in an elderly patient. | Int Cancer Conf J | 2024 | https://conductscience.org/library/papers/39398925 | PubMed |
| 37748835 | Regulatory miRNAs in cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrence. | Enzymes | 2023 | https://conductscience.org/library/papers/37748835 | PubMed |
| 35158893 | Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35158893 | PubMed |
| 32198424 | Thermal Analysis of Infrared Irradiation-Assisted Nanosecond-Pulsed Tumor Ablation. | Sci Rep | 2020 | https://conductscience.org/library/papers/32198424 | PubMed |
| 27277962 | Sound waves and antineoplastic drugs: The possibility of an enhanced combined anticancer therapy. | J Med Ultrason (2001) | 2002 | https://conductscience.org/library/papers/27277962 | PubMed |
| 26245485 | Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all. | Radiat Oncol | 2015 | https://conductscience.org/library/papers/26245485 | PubMed |
| 23814202 | Bleomycin-induced flagellate dermatitis. | BMJ Case Rep | 2013 | https://conductscience.org/library/papers/23814202 | PubMed |
| 6208924 | Inhibition of the recovery from potentially lethal damage by lonidamine. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6208924 | PubMed |
| 6205204 | Enhanced antitumor effects of bleomycin and moderate hyperthermia by additional use of ethanol. | Jpn J Surg | 1984 | https://conductscience.org/library/papers/6205204 | PubMed |
| 6199035 | New type of recovery in HeLa cells exposed to bleomycin. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6199035 | PubMed |
| 6193307 | Hyperthermo-chemo-radiotherapy for carcinoma of the esophagus. | Jpn J Surg | 1983 | https://conductscience.org/library/papers/6193307 | PubMed |
| 3404776 | Experimental studies of the effects of local hyperthermia on blood flow, oxygen pressure and pH in tumors. | Jpn J Surg | 1988 | https://conductscience.org/library/papers/3404776 | PubMed |
| 3006735 | Changes in the response of the RIF-1 tumour to melphalan in vivo induced by inhibitors of nuclear ADP-ribosyl transferase. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3006735 | PubMed |
| 2418860 | Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: I. In vitro cytotoxicity. | Br J Cancer | 1986 | https://conductscience.org/library/papers/2418860 | PubMed |
| 2418859 | Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: II. DNA damage, repair and chromatin changes. | Br J Cancer | 1986 | https://conductscience.org/library/papers/2418859 | PubMed |
| 2411985 | Radiation-induced esophageal carcinoma responded well to hyperthermic chemotherapy--a case report. | Jpn J Surg | 1985 | https://conductscience.org/library/papers/2411985 | PubMed |
| 2409315 | Synergistic effect of K-18 and concomitant hyperthermia for treatment of Lewis lung carcinoma in mice. | Jpn J Surg | 1985 | https://conductscience.org/library/papers/2409315 | PubMed |
| 1707464 | A new experimental trial using repeated heating every 24 hours for local hyperthermic therapy with bleomycin in vivo. | Jpn J Surg | 1990 | https://conductscience.org/library/papers/1707464 | PubMed |
| 137590 | The effect of hyperthermia on DNA repair. | Z Krebsforsch Klin Onkol Cancer Res Clin Oncol | 1976 | https://conductscience.org/library/papers/137590 | PubMed |
| 87213 | The interaction of thermal tolerance with drug cytotoxicity in vitro. | Br J Cancer | 1979 | https://conductscience.org/library/papers/87213 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/52401
GET https://conductscience.org/api/papers/v1/52401/cited_by?page=2